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Affinity maturation produces antibodies that bind antigens with high specificity by accumulating
mutations in the antibody sequence. Mapping out the antibody-antigen affinity landscape can
give us insight into the accessible paths during this rapid evolutionary process. By developing a
carefully controlled null model for noninteracting mutations, we characterized epistasis in affinity
measurements of a large library of antibody variants obtained by Tite-Seq, a recently introduced
Deep Mutational Scan method yielding physical values of the binding constant. We show that
representing affinity as the binding free energy minimizes epistasis. Yet, we find that epistatically
interacting sites contribute substantially to binding. In addition to negative epistasis, we report a
large amount of beneficial epistasis, enlarging the space of high-affinity antibodies as well as their
mutational accessibility. These properties suggest that the degeneracy of antibody sequences that
can bind a given antigen is enhanced by epistasis — an important property for vaccine design.
To ensure a reliable response and to neutralize for-
eign pathogens, the adaptive immune system relies on
affinity maturation. In this process, antibody receptors
expressed by B cells undergo an accelerated Darwinian
evolution through random mutations and selection for
affinity against foreign epitopes [1]. Mature antibodies
can accumulate up to 20% hypermutations, leading to
up to a 10,000 fold improvement in binding affinity [2].
Affinity maturation also produces broadly neutralizing
antibodies that target conserved regions of the pathogen,
of particular importance for vaccine design against fast
evolving viruses [3]. Despite extensive experimental and
theoretical work, the key determinants of antibody speci-
ficity and evolvability are still poorly understood, mainly
because the sequence-to-affinity relationship is difficult to
measure comprehensively or to predict computationally
[4].
A major confounding factor in characterizing the se-
quence dependence of any protein function, including
affinity, is the pervasiveness of epistasis, the phenomenon
by which different mutations interact with each other [5].
Theory [6–8] and genomic data [9] suggest that inter-
and intragenic epistasis plays a major role in molecu-
lar evolution, by constraining the set of accessible evo-
lutionary trajectories towards adapted phenotypes [10–
14], enhancing evolvability through stabilizing mutations
[15, 16], or slowing down adaptation by the law of dimin-
ishing returns [17, 18]. Evidence for epistasis in antibody
affinity include direct observations of cooperativity be-
tween mutations [19, 20], the dependence of mutational
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effects on sequence background [21], and statistical co-
variation of residues in large sequence datasets [22, 23].
Intragenic epistasis has mostly been studied either by
measuring the fitness of all possible mutational inter-
mediates between two variants [10, 24–27], or by com-
paring the effect of mutations in different backgrounds
[21, 28, 29]. Many such studies rely on a particular mea-
sure of fitness rather than a well-defined physical phe-
notype. Deep mutational scans (DMS) [30] can compre-
hensively map out the epistatic landscape of many ge-
netic variants [14, 31, 32]. However, most DMS methods
rely on noisy selection and do not measure the biophys-
ical quantity of interest directly [33], introducing both
nonlinearities and noise that could be misinterpreted as
epistasis.
Here we analyze the detailed epistatic landscape of
an antibody’s binding free energy to its cognate anti-
gen (the 4-4-20 antibody fragment against fluorescein),
using data previously obtained by Tite-Seq, a recently
introduced DMS variant that accurately measures pro-
tein binding affinity in physical units of molarity [34].
By comparing to a simple additive model of mutations
on the binding free energy, and carefully controling for
measurement noise and nonlinearities, we find that epis-
tasis significantly contributes to the antibody’s affinity.
This epistasis is not uniformly distributed, but instead
favors certain residue pairs across the protein. We use
our results to analyze how epistasis both constrains and
enlarges the set of possible evolutionary paths leading to
high-affinity sequences.
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FIG. 1. Additive model of binding affinity. (A) 4-4-20 scFv antibody sequence. Six complementarity determining regions
(CDR: 1L, 2L, 3L, 1H, 2H, 3H) are particularly important for antibody binding affinity. (B) A library of antibody sequences
with mutations in 10 amino-acid regions around the CDR1H and CDR3H domains were expressed using yeast display. Using
Tite-Seq, the binding constants KD of all 600 single codon mutants, 1100 random double codon mutants, and 150 random triple
codon mutants, were measured. (C) The KD of single mutants for 1H and 3H domains were used to create position weight
matrices (PWM) to predict the affinity of double and triple mutants. (D) Comparison between the PWM prediction and the
measurement of KD on double and triple mutants. The PWMs explained a significant portion of the variance, as quantified
by the explained variance R2 (p < 10−61 for CDR1H, p < 10−48 for CDR3H, F-test for reduction in variance due to PWM).
PWMs trained from the binding free energy, F = ln(KD/c0), outperformed PWM trained from KD (Fig. S1). We looked for
the optimal nonlinear transformation of KD maximizing the PWM fits (Methods and Fig. S2 for validation on simulated data)
and found that PWMs perform almost ideally when trained from the binding free energy (see Fig. S3).
RESULTS
Position Weight Matrix model of affinity
We analyzed data from [34] (https://github.com/
jbkinney/16_titeseq), where Tite-Seq was applied to
measure the binding affinities of variants of the 4-4-
20 fluorescein-binding scFv antibody, henceforth called
‘wildtype’. Libraries were generated by introducing mu-
tations to either the CDR1H or CDR3H domains re-
stricted to 10 amino acid stretches called 1H and 3H
(Fig. 1A). All single amino acid mutants, 1100 random
double amino acid mutants, and 150 triple amino acid
mutants were generated in multiple synonymous variants
and measured, (Fig. 1B). Using a combination of yeast
display and high-throughput sequencing at various anti-
gen concentrations, Tite-Seq yielded the binding dissoci-
ation constant KD (in M or mol/L) of each variant with
the fluorescein antigen.
We first tried to predict the KD of double and triple
mutants from single mutant measurements. Mutations
are expected to act on the binding free energy in an ap-
proximately additive way [32, 35]. One may thus write
the free energy of binding, F = ln(KD/c0) (defined up
to constant in units of kBT ), as a sum over mutations in
the mutagenized region, s = (s1, . . . , s`):
F (s) ≈ FPWM(s) = FWT +
∑`
i=1
hi(si), (1)
where FWT is the wildtype sequence energy, and hi(si) is
the effect of a mutation at position i to residue si. The
elements of the Position-Weight Matrix (PWM) hi(s) are
obtained from theKD of single mutants shown in Fig. 1C.
Since Tite-Seq measurements are limited to values of KD
ranging from 10−9.5 to 10−5, for consistency PWM pre-
dictions outside this range were set to the boundary val-
ues. The PWM was a fair predictor of double and triple
mutants (Fig 1D), accounting for 62% (p < 10−61, F-
test) of the variance for 1H mutants and 58% (p < 10−48,
F-test) of the variance of 3H mutants.
The unexplained variance missed by the PWM model
may have three origins: measurement noise, epistasis, or
nonlinear effects. The last case corresponds to the hy-
3pothesis of additivity not being valid for F = ln(KD/c0),
but for some other nonlinear transformation of F . Such
a nonlinearity, also called “scale,” can lead to spurious
epistasis [5, 36]. We first checked that additivity did not
apply to the untransformed dissociation constant, KD: a
PWM model learned from KD instead of F could only
explain 34% of the variance of all 1H and 3H multiple mu-
tants, down from 62% when learning from F (Fig. S1).
We then looked for the non-linear transformation E(F )
that would give the PWM model with the best predictive
power (Methods and Fig. S2). This optimization yielded
only a modest improvement to 65% of the explained vari-
ance. In addition, the optimal function E was very close
to the logarithm (R2 = 97%, Fig. S3). Since nonlinear
effects do not play a significant role, henceforth we only
consider the PWM model defined on the free energy.
Epistasis affects affinity
To identify epistasis, we estimated the difference be-
tween the measured binding free energies of double
and triple mutants, F (s), and the PWM prediction,
FPWM(s). However, these small differences can be con-
founded by measurement noise, which can be mistaken
for epistasis. To control for this noise, we defined Z-scores
between two estimates of the free energy, Fa and Fb, as
Z = (Fa − Fb)/
√
σ2a + σ
2
b , where σ
2
a and σ
2
b are their
estimates of uncertainty. We first computed Z-scores be-
tween independent estimates of the same free energy us-
ing synonymous variants (Zerror, Methods). We found
that the distribution of Zerror was normal with variance
≈ 1 (Fig. 2A, orange line), as expected from Gaussian
measurement noise.
We then estimated the effect of epistasis by calculat-
ing Z-scores (Zepi) from the difference between the PWM
prediction, FPWM (Eq. 1), and the measured F . The re-
sulting distributions of Z-scores (Fig. 2A, blue and red
lines) had much larger variances than expected from mea-
surement noise (standard deviation 3.34 for 1H, and 5.44
for 3H), indicating strong epistasis. These epistatic ef-
fects were on average slightly beneficial (positive Z): 25%
of double mutants inside the reliable readout boundaries
(10−9.5M ≤ KD ≤ 10−5M) showed significant benefi-
cial epistasis (Zepi > 1.64, p = 0.05), and 20% significant
deleterious epistasis (Zepi < −1.64). Comparing the vari-
ance of Zepi with that of Zerror gives a large fraction of
the unexplained variance that is attributable to epistasis,
1−Var(Zerror)/Var(Zepi) = 89% for 1H, and 96% for 3H.
To determine whether certain positions along the se-
quence concentrated epistatic effects, we computed the
mean squared Z-score for all double mutations at each
pair of positions (excluding median boundary values), re-
vealing a complex and heterogeneous landscape of epista-
sis (Fig. 2B and Fig. S5 for the epistasis magnitude super-
imposed on the wildtype’s crystal structure). CDR3H,
which interacts directly with the antigen, is observed to
have more epistatically interacting sites than CDR1H.
Interestingly, the three most epistatic pairs in 3H —
between positions 101, 106 and 108 — are mutated in
the previously described super-optimized 4m5.3 antibody
[37] (mutations shown in green in Fig. 1B), consistent
with previous suggestions that positions 101 and 106 in-
teract together and with position 108 via hydrogen bonds
[19, 34]. Epistasis is usually expected between residues
that are in contact in the protein structure [38–42], as
for instance between positions 101 and 106. However, the
mean squared Z-score weakly correlated with residue dis-
tance (r = −0.13, p = 0.21 for 1H, r = −0.34, p = 0.003
for 3H, Fig. S6).
We next looked for evidence of “sign epistasis,” where
one mutation reverses the sign of the effect of another
mutation (Fig. 2C). We defined a Z-score for a single
mutation A quantifying the beneficial effect of that mu-
tation relative to the noise, ZA = (FWT − FA)/σA, where
FWT and FA are the wildtype and mutant free ener-
gies, and σ is the measurement error estimated as be-
fore. Since we are only interested in the sign of the
effect, we keep single mutants at the reliable readout
boundary. An equivalent Z-score was defined for a mu-
tation A in the background of an existing mutation B:
ZA|B = (FB − FAB)/
√
σ2A + σ
2
AB , where FAB is the free
energy of the double mutant AB. Significant sign epista-
sis was defined by ZA|BZA < 0 and |ZA|B |, |ZA| > 1.64,
and reciprocal sign epistasis by the additional symmetric
condition A↔ B.
We found 44 cases of significant epistasis, listed in
S1_table_sign_epistasis.csv and summarized in Ta-
bles S1 and S2. Deleterious sign epistasis was excep-
tional, with just one instance in 1H and 4 in 3H (Fig. S4).
The four most significant cases of beneficial sign epistatis
for each domain are depicted in Fig. 2D. Among cases
where both single mutations were deleterious, we found
3% of mutants in 1H and 0.7% in 3H with significant
beneficial epistasis, versus 0.06% expected by chance (the
null expectation, which takes into account the constraint
that ZA+ZB|A = ZB+ZA|B , is defined in the Methods);
0.7% were reciprocal in 1H, and 0.3% in 3H, versus 0.01%
expected by chance. To evaluate how these epistatic in-
teractions may affect affinity maturation, we estimated
how often “viable” double mutants were separated from
the wildtype by nonviable single mutants, where viabil-
ity is defined by KD < 10
−6M [43–45], forming possible
roadblocks to affinity maturation. This strong instance
of “rescue” epistasis occured in roughly half of the mu-
tants with beneficial sign epistasis (Table S1 and S2).
Modeling epistasis and its impact on affinity
maturation
To integrate the observed epistatic interactions into a
predictive model of affinity, we introduced a model of
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FIG. 2. Quantification of epistasis. Epistasis is defined as deviation from the PWM model, which assumes an additive
effect of single mutations on the binding free energy F = ln(KD/c0) expressed in units of kBT . (A) Distribution of Z-scores,
defined as the normalized deviation from the PWM prediction, Zepi = (FPWM − F )/
√
σ2 + σ2PWM, where σ
2 and σ2PWM are
the estimated errors on F and FPWM. Positive Z-scores indicate epistasis increased affinity. The Z score standard deviation
was much higher than expected from measurement errors (Zerror) for CDR1H (3.34, p < 10
−33, Levene’s test) and CDR3H
(5.44, p < 10−52), meaning that the discrepancy between the PWM and measurement is mainly due to true epistasis. (B)
Standard Z-score deviation for each pair of positions along the sequence. This deviation is higher at pairs of positions mutated
in the super-optimized 4m5.3 antibody (green dots) in 3H (p = 0.005, Mann-Whitney), but not in 1H (p = 0.23). Pairs of
positions with large epistatic effects are shown on the wild-type crystal structure in Fig. S5. There is a weak correlation between
epistasis and distance between the residues (Fig. S6). (C) Schematic representation of sign and reciprocal sign epistasis for a
beneficial interaction. (D) Representative examples of sign epistasis as identified by Z-score. All 44 examples of beneficial sign
epistasis with double mutant KD ≤ 10−6 may be found in S1_table_sign_epistasis.csv, and summarized in tables S1 and
S2. Examples of deleterious sign epistasis are shown in figure S4.
binding free energy as:
F (s) ≈ Fpairwise(s) = FPWM(s) +
∑
i<j
Jij(si, sj), (2)
where J is the interaction strength between residues. To
avoid overfitting and allow for independent validation (in
the absence of a sufficient number of triple mutants), we
grouped residues into 4 biochemical categories [46] (po-
lar, nonpolar, acidic, basic, see Methods) and let the en-
tries of J only depend on that category.
We trained the model on the 1208 1H or 1216 3H dou-
ble and triple mutants, using a Lasso penalty to con-
trol for overfitting. The optimal penalty was set by 10
fold cross-validation, i.e. by maximizing the explained
variance of a subset comprising 1/10 of the mutants by
using a model trained on the remaining 9/10, averaged
over the 10 subsets (Fig. S7A and Methods). Interacting
pairs with posterior probabilities > 0.95 as determined
by Bayesian Lasso [47] are shown in Figs. 3A and B.
Out of the 720 possible terms, 52 1H and 45 3H inter-
action terms were identified by this method. Although
these interactions, whose number is limited by the num-
ber of measured variants, only modestly improved the
explained variance relative to the PWM in all multiple
mutants (from 62% to 64% for 1H and from 58% to 60%
for 3H), it substantially improved the affinity prediction
of the mutants with significant epistasis (R2 from 27%
to 50% in 1H, from 13% to 44% for 3H, Fig. S7B-C).
Notably, two mutations of the super-optimized 4m5.3
antibody are predicted by the model to have epistatic
interactions: a slightly deleterious effect between A101
and L108, and a strongly beneficial one between S102 and
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FIG. 3. Coarse-grained epistatic model. A model of biochemical epistatic interactions between polar, nonpolar, acidic,
and basic residues was fitted to the data using LASSO regularization and tested by cross-validation (Fig. S7A), yielding 1058
CDR1H and 1066 CDR3H interaction terms. Mean (A) beneficial and (B) deleterious interactions calculated by averaging
over all double mutants, colored by interaction type. Line width denotes interaction strength. The model performance on
significantly epistatic pairs of positions is shown in Figs. S7B-C, and the number of non vanishing parameters as a function
of the significance threshold on the posterior is shown in Fig. S7D. (C) Number V of amino-acid sequences of the 1H (blue)
and 3H (red) regions with dissociation constant below KD, as estimated by the PWM model (dark color) or the epistatic
model (light color). Epistasis enlarges the number of variants with good affinity for both 1H and 3H. (D) Mutational flux A
(defined as the average number of random mutation events from all possible sequences to cause the dissociation constant to
cross KD), normalized by V , showing that epistasis also increases the accessibility of the region of good binders in sequence
space. Differences between the PWM and epistatic models were robust to errors in the estimate of the interaction parameters
(p < 10−5, Jackknife analysis).
L108.
Next we used our models to estimate the diversity,
or “degeneracy”, of antibodies with good binding affin-
ity. Specifically, we evaluated the degeneracy volume
V of high-affinity sequences as the number of sequences
with KD < B, using either the PWM (Eq. 1) or pair-
wise (Eq. 2) models, using a combination of exhaustive
and Monte-Carlo sampling (Methods). Compared to the
coarse-grained pairwise model trained previously, the in-
teraction strength J was learned directly for each residue
pair, without grouping by biochemical category and with
no Lasso penalty. The volume of 1H mutants was larger
than that of 3H mutants (Fig. 3C), in agreement with the
fact that CDR3H plays a more important role in bind-
ing affinity. Epistasis increased the recognition volume
for both domains, consistent with the previous observa-
tion that epistatic effects are, on average, more benefi-
cial than deleterious. To explore the diversity of evolu-
tionary paths leading to recognition, we computed the
mutational flux A in and out of the high-affinity re-
gion as the probability that a random mutation in a
high-affinity sequence (KD < B) causes loss of recogni-
tion (KD > B), summed over all high-affinity sequences
(Methods). Again we found that epistasis increased the
mutational flux, even after normalizing by volume, A/V
(Fig. 3D). We checked that these differences were robust
to sampling noise and overfitting by performing a jack-
knife analysis (p < 10−5 for the difference in A and V
between the PWM and pairwise models, see Methods).
DISCUSSION
By analyzing massively parallel affinity measurements
obtained by Tite-Seq, we painted a detailed picture of
epistasis in a well-defined physical phenotype — the bind-
ing free energy of an antibody to an antigen. We showed
that antibody sequences contain many epistatic interac-
tions contributing to the binding energy, and that many
of them have beneficial effects. Our approach involves
first training an additive (PWM) model as a baseline,
and identifying departures from that model as epistasis.
In this comparison, a crucial step was to correct for the
6two issues of scale and measurement noise.
The first issue, identified by Fisher [36] and also called
unidimensional epistasis [25], is the idea that an epistatic
trait becomes additive upon a different parametrization.
For instance, protein stability, which often determines
fitness, is a nonlinear function of the folding free en-
ergy difference, which is expected to be roughly additive
[12, 27–29, 48–50]. This leads to both a law of dimin-
ishing returns [29] and robustness to mutations when the
protein is very stable [48]. To disentangle these poten-
tial artifacts, we defined our PWM on the binding free
energy, which we expect to be additive in sequence con-
tent, and we checked that this parametrization was close
to minimizing epistasis.
To tackle the second and perhaps more important is-
sue of noise, especially in the context of deep mutational
scans where many variants are tested [31], we devel-
oped a robust methodology based on Z-scores to identify
epistatic interactions as significant outliers. This anal-
ysis showed that almost all of the variance unexplained
by additivity (∼ 40%) could be attributed to epistasis,
making its contribution to the phenotype comparable to
that of single mutations. A large fraction of that epis-
tasis was beneficial, in contrast with previous reports of
mostly negative epistasis owing to the concavity of the
scale [24, 29, 49], which we here circumvent by directly
considering the free energy.
Epistasis is key to understanding the predictability and
reproducibility of evolutionary paths [18, 51]. Our re-
sults show how it could constrain the space of possi-
ble hypermutation trajectories during affinity matura-
tion, with important consequences for antibody and vac-
cine design, as the importance of eliciting responses of
antibodies that are not just strongly binding but also
evolvable is being increasingly recognized [52]. Targeting
epistatic interactions may provide an alternative strategy
for optimizing antibody affinity: among the 12 epistatic
hotspots in CDR1H and 20 in CDR3H that we identi-
fied (〈Z2epi〉
1
2 > 3), 4 involved positions mutated in the
super-optimized 4m5.3 antibody sequence, with a higher
epistatic contribution than expected by chance. We also
identified 3 cases of beneficial sign epistasis, in which the
double mutant was fit despite the single mutant being
deleterious. For instance, the D108E mutations in 4m5.3
is deleterious by itself but is rescued beyond the wildtype
value by the S101A mutation [19], which occurred first in
the directed evolution process [37]. We report 10 extreme
cases of viable double mutants whose single-mutant inter-
mediates are nonviable, possibly blocking affinity matu-
ration. However, our analysis of the volume and mu-
tational flux of the region of low binding free energies
in sequence space suggests that epistasis facilitates the
evolution of high-affinity antibodies. Additionally inter-
actions with the non-mutated parts of the sequence and
evolution of the antigen binding partner can either add
further constraints or open up additional paths.
Taken together, our results show the importance of
taking into account epistasis when predicting antibody
evolution and guiding vaccine design. Our systematic
approach for identifying and quantifying epistasis, with
the implementation of important controls for scale and
noise, could be used by other investigators to analyze
deep-mutational scans of protein function.
METHODS
Values of KD as measured by Tite-Seq for variants of
the 4-4-20 fluorescein-binding antibody [34] can be found
at https://github.com/jbkinney/16_titeseq. The
scripts used for the analyses presented here are available
at https://github.com/rhys-m-adams/epistasis_4_
4_20.
Position Weight Matrix
The amino-acid sequence of the 10 amino acid stretches
of the CDR1H or CDR3H domains are denoted by s =
(s1, . . . , s10). The corresponding 30-long nucleotide se-
quences are denoted by v. The binding free energy F (s)
of an amino-acid variant is obtained as the mean over 3
replicate experiments, and over all its synonymous vari-
ants:
F (s) =
1
N(s)
∑
a
∑
v∈Sa(s)
ln(KD(v, a)/c0), (3)
where Sa(s) is the set of measured nucleotide sequences
that translate to s in replicate a, and N(s) =
∑
a |Sa(s)|
a normalization constant.
The elements of the PWM are defined as hi(q) =
F (s(i,q)) − FWT , where s(i,q) is the single mutant mu-
tated at position i to residue q, and hi(q) = 0 when q is
the wildtype residue at position i.
Optimal nonlinear transformation of the free energy
To test whether transforming F through a nonlinear
function E(F ) before learning the PWM could improve
its predictive power, we defined the nonlinear additive
model:
F (s) ≈ f [EPWM(s)], EPWM(s) = EWT +
∑
i
h˜i(si),
(4)
where f = E−1 is the inverse function of E, h˜i(q) =
E(s(i,q))−EWT, and E(s) is evaluated similarly to Eq. 3:
E(s) = (1/N(s))
∑
a
∑
v∈Sa(s)E[ln(KD(v)/c0)].
To find the transformation E that gives the highest
explained variance while avoiding overfitting, we aimed
to minimize the following objective function:
O[E] =
∑
s
[EPWM(s)− E(s)]2 + α
∫
dF |E′′(F )|2, (5)
7where the sum in s runs over double and triple mutants,
and α is a tunable parameter.
Numerically, we parametrize the function E(F ) as
piecewise linear: E(F ) = Ei × (Fi+1 − F )/δF + Ei+1 ×
(F−Fi)/δF for Fi ≤ F ≤ Fi, where Fi are equally spaced
grid point along F , δF = Fi+1−Fi, and Ei the value of E
at these points. The smoothing penalty is approximated
by a sum over the squared discretized second derivative:∫
dF |E′′(F )|2 ≈∑i(Ei+1 + Ei−1 − 2Ei)2/δF 3.
We minimize O[E] ≈ O[E1, . . . , EN ] as a quadratic
function of its arguments (Ei), while imposing boundary
constraints on the PWM prediction and the requirement
that E is a increasing function of F (i.e. Ei+1 > Ei),
using the python package cvxopt [53].
The hyper-parameter α is evaluated by maximizing the
generalized cross-validation of the coefficient of determi-
nation
R2 = 1−
〈∑
s∈S [E
\S
PWM(s)− E\S(s)]2
Vars∈S [E\S(s)]
〉
S
, (6)
where E\S and E\SPWM(s) are learned through optimizing
Eq. 5, but after removing from the dataset a subset S of
the multiple mutants comprising one tenth of the total.
The average is over ten non-overlapping subsets S.
This method was first tested on simulated data. Each
PWM element h˜i(q) was drawn from a normal distri-
bution of zero mean and variance 1, and then EPWM(s)
was computed for each of the antibody sequences present
in our data. Our simulated “measurement” was defined
as a function of a noisy realization of E = EPWM + 
(where  is some Gaussian noise) in three different ways:
linear F = E, exponential F = exp(E), high-frequency
F = 2E + sin(2E), and logistic F = 1/[1 + exp(−E)]. 
was drawn from a centered normal distribution with 1/2
the standard deviation of EPWM. F was then truncated
to the 200th lowest and 200th highest values, to mimick
the boundary cutoff in our measurements. Comparing
our original EPWM to our fit Eˆ shows that our method
is able to infer the true PWM model and a smooth non-
linearity from noisy data (Fig. S2).
We then applied the method to the experimental data.
The cross-validation R2 is represented as a function of the
smoothing parameter α in Fig. S3A, and the correspond-
ing optimal function E(F ) in Fig. S3B. The comparison
between measurement and the PWM model is shown in
Fig. S3C.
Z-scores
We used synonymous mutants to estimate our mea-
surement error. The mean free energy of a nucleotide
sequence is defined as the mean over replicate measure-
ments: F (v) = 〈ln(KD(v, a)〉a, and the standard error
σ(v) is defined accordingly as the pooled error over repli-
cates. Antibodies with KD having median values at the
boundary values of 10−9.5 or 10−5 were excluded from
the analysis since these values artificially cluster at the
boundary, leading to underestimates of error.
The error Z-score was calculated between pairs of nu-
cleotide sequences with the same amino acid translation:
Zerr(v,v
′) = (F (v)− F (v′))/√σ(v)2 + σ(v′)2.
Epistatic Z-scores were estimated by calculating the
measurement error over both replicates and synonymous
variants, as in Eq. 3:
σ2(s) =
∑
a
∑
v∈Sa(s) [ln(KD(v, a)/c0)− F (s)]
2
N(s)(N(s)− 1) , (7)
and the pooled standard error for a PWM prediction,
calculated as the sum of measurement errors from single
mutations:
σ2PWM(s) =
∑
i
σ2i (si), (8)
where σi(q) = σ(s
(i,q)), and σi(q) = 0 when q is the
wildtype residue at i. The epistatic Z-score is defined as:
Zepi(s) =
FPWM(s)− F (s)√
σ2(s) + σ2PWM(s)
. (9)
Null model for sign epistasis
To calculate p-values for sign epistasis, we used the
following null model for sets of four Z-scores satisfy-
ing ZA + ZB|A = ZB + ZA|B . Calling x1 = ZA, x2 =
ZB|A, x3 = −ZA|B , x4 = −ZA, the condition becomes
that each xi has zero mean and variance one, with the
constraint
∑4
i=1 xi = 0. The distribution with maxi-
mum entropy satisfying these requirements is a centered
multi-variate Gaussian uniquely defined by its covariance
matrix 〈x2i 〉 = 1 and 〈xixj〉 = −1/3 for i 6= j. The p-
value for sign epistasis, ZA > 1.64 and ZA|B < 1.64, was
estimated by Monte Carlo sampling under that Gaussian
distribution as Pr(x1 > 1.64 & x2 > 1.64) + Pr(x3 >
1.64 & x4 > 1.64)− Pr(x1 > 1.64 & x2 < −1.64 & x3 >
1.64 & x4 < −1.64) = 6.2 · 10−4, and the probability
for reciprocal sign epistasis as Pr(x1 > 1.64 & x2 <
−1.64 & x3 > 1.64 & x4 < −1.64) = 10−4.
Epistatic model
The epistatic terms of the pairwise model were made
to depend on the biochemical categories of the interact-
ing residues, Jij(si, sj) = J˜ij(b(si), b(sj)), with b(s) =
nonpolar for s = AFGILMPVW, b(s) = polar for s =
CNQSTY, b(s) = acidic for s = DE, and b(s) = basic
for s = HKR. A fifth category was added to corre-
spond to the wildtype residue, so that J˜ij(wildtype, b) =
J˜ij(b,wildtype) = 0. The model was trained by minimiz-
ing the mean squared error with a regularization penalty
8over all matrices J˜ij(b, b
′):∑
s
[
F (s)− Fpairwise(s, J˜)
]2
+ λ
∑
ijbb′
|J˜ij(b, b′)|. (10)
The Lasso penalty λ was learned by 10-fold cross-
validation, and energy terms found in less than 2 se-
quences were excluded from the fit. Posterior values for
J˜ terms were calculated using Bayesian Lasso [47].
The volume and mutational flux were defined as:
V (B) =
∑
s
Θ(B −KD(s)) (11)
A(B) =
∑
s
Θ(B −KD(s)) 1
19`
∑
s′|d(s,s′)=1
Θ(KD(s
′)−B),
(12)
where Θ(x) is the Heaviside function, i.e. Θ(x) = 1
if x ≥ 0 and 0 otherwise; d(s, s′) is the Hamming dis-
tance between two sequences; and ` = 10 is the sequence
length. The normalization 19×` corresponds to the num-
ber of mutants s′ at Hamming distance 1 from s. The
sums over s in Eqs. 11-12 have 2010 elements and are
computationally intractable. To overcome this, we ap-
proximated the sum using a mixture of Monte-Carlo and
complete enumeration, depending on the distance of s
from the wildtype. Calling Cd the set of sequences s at
Hamming distance d from wildtype, we used:
∑
s
g(s) ≈
∑`
d=0
|Cd|
|C˜d|
∑
s∈C˜d
g(s), (13)
where g(s) is a function of s to be summed such as in
V or A in Eqs. 11-12, and C˜d is a random subset of
Cd of size min(|Cd|, Pd), with Pd =
(
`
d
) × (bP/(`d)c + 1),
where P is the maximum number of sequences one is
willing to sample completely at each d to perform the
estimation, and where |Cd| =
(
`
d
)
19d. For small d, when
|Cd| ≤ Pd, the enumeration is complete, while for large
d and |Cd| > Pd, the sum is estimated from a uniformly
distributed Monte Carlo sample of Cd.
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domain # of
nonviable
single
mutations
epistasis type # candidate
mutants
# of mutants
with sign
epistasis
(obs/exp)
# of mutants
with
reciprocal
sign epistasis
(obs/exp)
# of viable
mutants with
sign epistasis
(obs/exp)
# of viable
mutants with
reciprocal
sign epistasis
(obs/exp)
# of sign
epistatic
mutants with
KD < WT
(obs/exp)
1H 0 beneficial 293 2/0.21 0/0.04 2/0.06 0/0.01 0/0.01
1H 1 beneficial 532 16/0.32 0/0.05 16/0.09 0/0.02 2/0.01
1H 0, 1 beneficial 825 18/0.53 0/0.09 18/0.15 0/0.03 2/0.02
1H 2 beneficial 172 14/0.10 7/0.02 12/0.03 6/0.01 0/0.01
1H 0− 2 beneficial 997 32/0.63 7/0.11 30/0.18 6/0.03 2/0.02
1H 0− 2 deleterious 53 1/0.63 0/0.11 0/0.18 0/0.03 0/0.02
TABLE S1. Summary of CDR1H sign epistasis with double mutants. Obs/exp denotes observed sign epistasis events versus
expected epistasis events in a Gaussian noise model. Expected numbers below 0.01 are rounded up to 0.01. We measured 1058
CDR1H double mutants in total.
domain # of
nonviable
single
mutations
epistasis type # candidate
mutants
# of mutants
with sign
epistasis
(obs/exp)
# of mutants
with
reciprocal
sign epistasis
(obs/exp)
# of viable
mutants with
sign epistasis
(obs/exp)
# of viable
mutants with
reciprocal
sign epistasis
(obs/exp)
# of sign
epistatic
mutants with
KD < WT
(obs/exp)
3H 0 beneficial 173 2/0.11 0/0.02 2/0.01 0/0.01 1/0.01
3H 1 beneficial 525 2/0.31 0/0.05 0/0.04 0/0.01 0/0.01
3H 0, 1 beneficial 698 4/0.42 0/0.07 2/0.05 0/0.01 1/0.01
3H 2 beneficial 359 3/0.21 3/0.04 3/0.03 3/0.01 0/0.01
3H 0− 2 beneficial 1057 7/0.63 3/0.11 5/0.08 3/0.01 1/0.01
3H 0− 2 deleterious 97 4/0.63 0/0.11 3/0.08 0/0.01 0/0.01
TABLE S2. Summary of CDR3H sign epistasis with double mutants. Obs/exp denotes observed sign epistasis events versus
expected epistasis events in a Gaussian noise model. Expected numbers below 0.01 are rounded up to 0.01. We measured 1066
CDR3H double mutants in total.
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FIG. S1. Comparison between data and model prediction of the binding affinity of multiple mutants using PWMs constructed
from A) KD and B) F = ln(KD/c0). R
2 denotes the coefficient determination (fraction of explained variance). Although both
predictions are very significant (p < 10−5, F-test), the PWM based on F is much better.
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FIG. S2. Test of the inference method for learning the nonlinear scale on synthetic data. A PWM was generated randomlly, with
terms drawn from a normal distribution, and applied to the sequences from our dataset to simulate a “true” score (EPWM).
Gaussian noise with 50% of the standard deviation of EPWM was added. The score was the converted into a free energy
F = f(E) (Methods), where f , the inverse function of E, was a (A) linear, (B) exponential, (C) high frequency, or (D) logistic
transformation. The range of measured F was cut off at the boundaries as in the data, resulting in the vertical lines in the right
panels. Left panels: cross-validated fraction of explained variance, as a function of the regularization parameter α penalizing the
second derivative of the function E. Large α implies very smooth functions, while small α allows for high-frequency variations.
These results the original PWM can be recovered as well as the non-linearity, except for its high-frequency components (C).
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FIG. S3. Optimizing the non-linear scale E for the PWM model on real data. (A) Cross-validated fraction of explained
variance, as a function of the regularization parameter α penalizing the second derivative of the function E. (B) Optimized
non-linear scale E as a function of F = ln(KD/c0) (black), compared to identity (red). (C) Comparison between data and the
PWM model with the optimal nonlinear scale.
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FIG. S7. Inferrence of the epistatic model. Left panels correspond to the 1H domain, and right panels to the 3H domain.
Parameters were fit by minimizing the mean squared model error with a L1 penalty on the parameters with coefficient λ. (A)
The cross-validated coefficient of determination (1− standard error2/standard deviation2) has a clear maximum as a function
of λ. (B) and (C) Model prediction versus measurement of F = ln(KD/c0), for sequences involving a non-zero interacting
term, when using (B) the PWM model and (C) the epistatic model with optimal λ. (D) Rank-ordered posterior probability of
J˜ parameters to be non-zero, according to the Bayesian Lasso posterior [47]. Monte Carlo Markov Chains (MCMC) were used
to estimate posterior probability of a parameter switching signs. Multiple (2 × number of non-zero parameters from Lasso
optimization + 2) MCMCs were initialized (“thermalized”) for 227 steps × the number of parameters. After thermalization,
the MCMCs were simulated for another 454 steps × the number of parameters. Parameter values were sampled at intervals
where their autocorrelations were ≤ 0.1. The posterior probabilty was calculated as the fraction of time the parameter switched
signs in the MCMCs.
